डॉ. अग्रवाल हेल्थ केअर शेअर किंमत

Healthcare Facilities company Dr. Agarwals Health Care announced Q3FY26 results As of December 31, 2025, our network stands at 272 facilities, with 14 new centers added during the quarter comprising of 9 secondary and 5 primary facilities. Performed 81,002 surgeries in Q3FY26, growth of 11.2% YoY. Total Income of Rs 540 crore; growth of 21.9% YoY. Revenue from Operations of Rs 530 crore; growth of 23.0% YoY. Revenue from Operations - India of Rs 480 crore, growth of 23.1% YoY. Revenue from Mature Facilities of Rs 405 crore, growth of 37.8% YoY. Sale of Services contributed 78.8% and Sale of Products contributed 21.2% to revenue from operations. EBITDA of Rs 155 crore, growth of 21.3% YoY with EBITDA margins of 28.6%. Profit after Tax of Rs 44 crore, growth of 54.5% YoY with profit after tax margins of 8.1%. Adil Agarwal, CEO, Dr. Agarwal’s Health Care, said: “The Company delivered a strong performance in Q3FY26, marked by robust growth across revenues and profitability, reflecting sustained execution momentum. For the Q3FY26, Revenue from Operations grew by 23.0% YoY to Rs 530 crore, driven by healthy patient volumes, strong traction across mature centres, and improving contribution from newer facilities. EBITDA increased by 21.3% YoY to Rs 155 crore, underscoring the resilience of the operating model and disciplined cost management. On the operational front, our network expanded to 272 eye care facilities as of December 31, 2025 with 38 additions during the nine months period ending December, 2025. We served over 22 lakh patients and performed over 238,000 surgeries, supported by our team of 900+ doctors. The Company remains focused on accelerating organic growth through aggressive greenfield expansion, deepening its presence in existing markets while selectively entering newer geographies. Leveraging its brand strength and scalable platform, Dr. Agarwal’s Healthcare continues to drive sustainable growth while maintaining high standards of patient safety and clinical quality. The Company remains confident of meeting its annual guidance, supported by resilient demand and strong momentum in its expansion plans.” Result PDF

• ट्रेंडलाईन
• 3 महिने 2 आठवड्यांपूर्वी

Healthcare Facilities company Dr. Agarwals Health Care announced Q2FY26 results As of September 30, 2025, our network stands at 258 facilities, with 11 new centers added during the quarter comprising of 6 secondary and 5 primary facilities - Performed 78,399 surgeries in Q2FY26, growth of 13.3% YoY. Total Income of Rs 507 crore; growth of 18.2% YoY. Revenue from Operations of Rs 499 crore; growth of 19.7% YoY. Revenue from Operations. India of Rs 445 crore, growth of 19.8% YoY. Revenue from Mature Facilities of Rs 371 crore, growth of 12.7% YoY. Sale of Services contributed 78.1% and Sale of Products contributed 21.7% to revenue from operations. EBITDA of Rs 144 crore, growth of 21.2% YoY with EBITDA margins of 28.4%. Profit after Tax of Rs 36 crore, growth of 71.0% YoY with profit after tax margins of 7.2%. Adil Agarwal, CEO, Dr. Agarwal’s Health Care, said: “The company delivered a steady performance in H1FY26 crossing the Rs 1,000 crore Total Income milestone for the first time — marking a significant achievement in its growth journey. EBITDA for H1FY26 grew by 24.9% YoY to Rs 285 crore, and profit after tax rose by 88.4% to Rs 75 crore, reflecting improved operating efficiencies, disciplined cost management, and stronger margins. While topline growth moderated compared to the previous quarter due to festivities and heavy rainfall, margins strengthened, demonstrating continued focus on profitability and operational excellence. On the operational front, our network expanded to 258 eye care facilities as of September 30, 2025 with 24 additions during the first half. We served over 14 lakh patients and performed over 157,000 surgeries, supported by our team of 880+ doctors. Our recent entry into the Delhi market has seen encouraging traction, and we plan to further accelerate our expansion across North India. We remain confident of meeting our annual guidance, driven by resilient demand and the momentum in our expansion plans. As the second half of the year typically delivers stronger performance, we expect the momentum to further build through FY26.” Result PDF

• ट्रेंडलाईन
• 6 महिने 3 आठवड्यांपूर्वी

Conference Call with Dr. Agarwals Health Care Management and Analysts on Q1FY26 Performance and Outlook. Listen to the full earnings transcript.

• ट्रेंडलाईन
• 9 महिने 1 आठवड्यापूर्वी